Capital Impact Advisors’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-189,437
| Closed | -$1.39M | – | 126 |
|
|
2019
Q1 | $1.39M | Hold |
189,437
| – | – | 0.61% | 94 |
|
|
2018
Q4 | $1.39M | Buy |
189,437
+96,548
| +104% | +$706K | 0.59% | 97 |
|
|
2018
Q3 | $1.39M | Buy |
92,889
+4,473
| +5% | +$67.1K | 0.48% | 110 |
|
|
2018
Q2 | $1.69M | Buy |
88,416
+19,309
| +28% | +$370K | 0.63% | 93 |
|
|
2018
Q1 | $1.21M | Buy |
69,107
+21,981
| +47% | +$385K | 0.5% | 111 |
|
|
2017
Q4 | $1.16M | Hold |
47,126
| – | – | 0.5% | 111 |
|
|
2017
Q3 | $1.22M | Buy |
47,126
+22,140
| +89% | +$571K | 0.54% | 109 |
|
|
2017
Q2 | $678K | Sell |
24,986
-9,572
| -28% | -$260K | 0.31% | 145 |
|
|
2017
Q1 | $1.03M | Buy |
+34,558
| New | +$1.03M | 0.41% | 129 |
|